Guido Rasi and Luis Salaices were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Rasi and Luis Salaices were featured in the government and policy section, as LSIPR reports.
Name: Guido Rasi
Organisation: European Medicines Agency
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Guido Rasi, Luis Salaices, European Medicines Agency, CRISPR gene-editing technology, International Union for the Protection of New Varieties of Plants,
